Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Do You Have a Position in Align Technology? Here's the Essential Facts.

Shares of Align Technology have moved 1.3% today, and are now trading at a price of $152.82. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 85,501 compared to the stock's average volume of 1,379,704.

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. Based in Tempe, United States the company has 21,065 full time employees and a market cap of $11,077,366,784.

The company is now trading -16.98% away from its average analyst target price of $184.07 per share. The 14 analysts following the stock have set target prices ranging from $150.0 to $220.0, and on average give Align Technology a rating of buy.

Over the last 12 months ALGN shares have declined by -35.9%, which represents a difference of -48.1% when compared to the S&P 500. The stock's 52 week high is $246.19 per share and its 52 week low is $122.0. With its net margins declining an average -8.5% over the last 6 years, Align Technology declining profitability gives us reason to believe its stock price will continue to underwhelm.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2024 3,999,012 421,362 11 -8.33
2023 3,862,260 445,053 12 20.0
2022 3,734,635 361,573 10 -50.0
2021 3,952,584 772,020 20 -72.22
2020 2,471,941 1,775,888 72 300.0
2019 2,406,796 442,776 18
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS